Market research reports on: DNA, RNA, proteomics, genomics, genetics, cancer, cell, protein, sequencing, biomarkers, peptides, in vitro diagnostics, molecular and others.
Let's ConnectCurrent Research & Development Status of Chimeric Antigen Recepto...
The global market for chimeric antigen receptor (CAR) T-cell therapy is estimated to grow from $1.5 billion in 2021 to reach $7.6 billion by 2026, at a compound annual growth rate (CAGR) of 39.1% during 2021-2026.
Cell Separation Techniques - Magnetic and Flow-Based Models: Glob...
The global cell separation techniques market should reach $4.4 billion by 2026 from $3.1 billion in 2021 at a compound annual growth rate (CAGR) of 7.0% for the forecast period of 2021 to 2026.
The U.S. Market for Biodefense-Related Rapid Pathogen Identificat...
The U.S. biodefense-related rapid pathogen identification and treatment market should reach $518.3 million by 2026 from $366.3 million in 2021 at a compound annual growth rate (CAGR) of 7.2% for the forecast period of 2021 to 2026.
RNA Analysis Market
The global market for RNA analysis/transcriptomics should grow from $8.3 billion in 2021 to $13.4 billion by 2026, at compound annual growth rate (CAGR) of 9.9% for the period of 2021-2026.
Global Markets for Media, Sera and Reagents in Biotechnology
The global market for media, sera and reagents in biotechnology is estimated to grow from $5.0 billion in 2021 to $7.4 billion by 2026 at a compound annual growth rate (CAGR) of 7.9% of during the forecast period of 2021-2026.
Biological Therapies for Cancer: Technologies and Global Markets
The global cancer biologics market should reach $143.0 billion by 2026 from $77.5 billion in 2021 at a compound annual growth rate (CAGR) of 13.0% for the forecast period of 2021 to 2026.
High Content Screening/Imaging: Technologies and Global Markets
The global market for high content screening/imaging technology should grow from $1.2 billion in 2021 to $2.3 billion by 2026 with a compound annual growth rate (CAGR) of 13.5% for the period of 2021-2026.
DNA Vaccines: Technologies and Global Markets
The global market for DNA vaccines should grow from $3.1 billion in 2021 to $11.5 billion by 2026 with a compound annual growth rate (CAGR) of 30.1% for the period of 2021-2026.
Global Markets and Manufacturing Technologies for Protein Drugs
The global protein drugs market should reach $394.2 billion by 2026 from $265.0 billion in 2021 at a compound annual growth rate (CAGR) of 8.3% for the forecast period of 2021 to 2026.
Autoimmune Disease Diagnostics: Global Markets
The global market for autoimmune disease diagnostics should grow from $13.7 billion in 2021 to $17.0 billion by 2026 with a compound annual growth rate (CAGR) of 4.4% for the period of 2021-2026.
Global DNA Sequencing: Research, Applied and Clinical Markets
The global market for DNA Sequencing should grow from $15.7 billion in 2021 to $37.7 billion by 2026, at compound annual growth rate (CAGR) of 19.1% for the period of 2021-2026.
Global Markets for Enzymes in Industrial Applications
The global market for enzymes in industrial applications should grow from $6.4 billion in 2021 to $8.7 billion by 2026, at compound annual growth rate (CAGR) of 6.3% for the period of 2021-2026.
Soft Tissue Allografts: Global Markets
The global market for soft tissue allografts should grow from $5.1 billion in 2021 to $6.6 billion by 2026, at compound annual growth rate (CAGR) of 5.3% for the period of 2021-2026.
Kinase Inhibitors: Global Markets
The global market for kinase inhibitors should grow from $57.6 billion in 2021 to $79.2 billion by 2026 with a compound annual growth rate (CAGR) of 6.6% for the period of 2021-2026.
Biosimilars: Global Markets
The global biosimilars market should reach $60.1 billion by 2025 from $15.7 billion in 2020 at a compound annual growth rate (CAGR) of 30.9% for the forecast period of 2020 to 2025.
Liquid Biopsy Research Tools, Services and Diagnostics: Global Ma...
The global market for liquid biopsy should increase from $3.8 billion in 2020 to $19.6 billion by 2025, at a compound annual growth rate (CAGR) of 38.5% during the period of 2020-2025.
Biomarkers: Technologies and Global Markets
The global market for biomarkers should grow from $43.3 billion in 2020 to $92.1 billion by 2025, at compound annual growth rate (CAGR) of 16.3% for the period of 2020-2025.
Artificial Intelligence (AI) in HIV/AIDS
The goal of this short study is to provide a detailed review of how AI is being applied in fighting HIV/AIDS. The report evaluates the utilization of various AI tools (e.g., machine learning, natural language processing, image processing, speech recognition) in diagnosis, therapy, research and development, and health management (e.g., patient data, insurance information, and hospital stay) as it relates to HIV/AIDS. Also, emphasis is given to the types of algorithms (e.g., artificial neural networks, deep learning) that have been developed so far in the field of HIV/AIDS.
Artificial Intelligence (AI) in Cancer
The goal of this short study is to provide a detailed review of how AI is being applied in fighting cancer. The report will evaluate the utilization of various AI tools (e.g., machine learning, natural language processing, image processing, speech recognition) in diagnosis, therapy, research and development, and health management (e.g., patient data, insurance information, and hospital stay) as it relates to cancer. Also, emphasis will be given to the types of algorithms (e.g., artificial neural networks, deep learning) that have been developed so far in the field of cancer.
Cloud Computing in Cell Biology, Genomics and Drug Development
The global market for cloud computing applications in cell biology, genomics and drug development should grow from $2.2 billion in 2019 to $6.4 billion by 2024, with a compound annual growth rate (CAGR) of 23.4% during the period of 2019-2024.
Artificial Intelligence (AI) in Alzheimer's Applications
AI is impacting many sectors, including healthcare. Within this sector AI is providing breakthrough in diagnostics, therapeutics, patients recovery time and outcomes, and health management. AI is being applied in the diagnosis and treatment of various medical conditions, in particular to solve some of the critical issues related to hard-to-cure diseases, such as Alzheimer’s (AD). This report summarizes the most relevant applications of artificial intelligence in AD and the various categories of supervised learning algorithms used in Alzheimer’s and their applications.
Genomics and Proteomic Tools for Emerging Markets in Asia-Pacific
The Asia-Pacific genomics and proteomics tools market should reach $5.9 billion by 2023 from $4.0 billion in 2019 at a compound annual growth rate (CAGR) of 10.4% for the forecast period of 2019 to 2023.
Highs and Lows of Stem Cell Therapies: Off-The-Shelf Solutions
This report will review the current commercial and regulatory landscape for the stem cell therapies, and assesses the challenges and opportunities for developing autologous and allogenic “off the shelf” solutions to treat a broad range of diseases and injuries.
Predisposition Biomarkers: Technologies and Global Markets
This comprehensive report provides an in-depth assessment of the global market for predisposition biomarker technologies. The report’s key objective is to analyze areas of opportunities, key developments and the impact of this technology on industry, specifically the pharmaceutical, biotechnology and healthcare sectors. The analysis also reviews the adoption of predisposition biomarker technologies in developed and emerging markets.
Global Cryostat Microtome Equipment Market
The global market for cryostat microtome should grow from $43.4 million in 2019 to $60.6 million by 2024 with a compound annual growth rate (CAGR) of 6.9% for the period of 2019-2024.
Choose your License
AI in Clinical and Molecular Diagnostics Market
This report explains critical trends in AI in clinical and molecular diagnostic industry. The report examines market determinants that serve as driving or inhibiting factors, offering valuable insights to stakeholders and potential entrants.
Commercial Amino Acids
This report outlines the properties of the 20 commercial essential amino acids that are delineated in the genetic code.
Induced Pluripotent Stem Cells: Global Markets
This report focuses on the market size and segmentation of iPSC products, including iPSC research and clinical products.
Global DNA Sequencing: Research, Applied and Clinical Markets
This report aims to provide detailed market, technology, and industry analyses to help readers quantify and qualify the market for DNA sequencing. Important trends are identified, and sales forecasts by technology, product & services, end-user, application, and disease category are provided through 2029.
Single-use Technologies for Biopharmaceuticals: Global Markets
The report discusses single-use technologies and bioreactors to produce pharmaceuticals and provides in-depth market analysis.
Cell and Gene Therapy Tools, and Reagents: Global Markets
This report provides a comprehensive analysis of product types, applications, and end-users of cell and gene therapy tools and reagents, along with a critical perspective of the industry's trends, future potential, and direction.